Abivax Bolsters Commercial Leadership with James Berger Appointment

Abivax has strengthened its Commercial Leadership Team by appointing James Berger as Global Head of Marketing. Berger brings over 20 years of experience in commercial biopharmaceutical leadership, having led brand strategy and product launches across various therapeutic areas.

Prior to joining Abivax, Berger held a similar role at Amgen as Global Franchise Head, where he oversaw global brand strategy and franchise growth. Before that, he spent over a decade at Takeda shaping the strategy, launch, and growth of an inflammatory bowel disease brand.

As part of his new role, Berger will lead commercial strategy and brand development at Abivax. Michael Nesrallah, Chief Commercial Officer of Abivax, commented on the appointment: 'We are strengthening our Commercial Leadership Team with an accomplished executive who brings deep expertise in inflammatory bowel disease.'